Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank50
3Y CAGR-18.0%
5Y CAGR+36.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-18.0%/yr
Annual compound
5Y CAGR
+36.4%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
4.7x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.13 | -49.6% |
| 2024 | 0.27 | +22.9% |
| 2023 | 0.22 | -10.9% |
| 2022 | 0.24 | +67.4% |
| 2021 | 0.15 | +411.5% |
| 2020 | 0.03 | - |
| 2019 | 0.00 | +100.0% |
| 2018 | -3.91 | -109.5% |
| 2017 | -1.87 | - |